Mitigating the burden of hepatitis C virus among people who inject drugs in Belgium

Acta Gastro-Enterologica Belgica

Volumn 79, Issue 2, 2016, Pages 227-232

  Matheï, Catharina ^a   Bourgeois, Stefan ^b   Blach, Sarah ^c   Brixko, Christian ^d   Mulkay, Jean Pierre ^e   Razavi, Homie ^c   Robaeys, Geert ^f,g,h  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b ZNA Campus Stuivenberg ^*  (Belgium)

^c Center for Disease Analysis   (United States)

^d Centre Hospitalier Regional de La Citadelle   (Belgium)

^e SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^f DEPARTMENT OF CARDIOLOGY   (Belgium)

^g HASSELT UNIVERSITY   (Belgium)

^h UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Hepatitis C; Incidence; Injecting drug users; Prevalence; PWID; Transmission

Indexed keywords

ANTIVIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; BELGIUM; DRUG USE; HARM REDUCTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; PEOPLE WHO INJECT DRUG; POPULATION MODEL; PREVALENCE; SECONDARY INFECTION; VIRUS TRANSMISSION; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; THEORETICAL MODEL; TRANSMISSION;

ANTIVIRAL AGENTS; BELGIUM; DRUG USERS; HARM REDUCTION; HEPATITIS C; HUMANS; INCIDENCE; MODELS, THEORETICAL; PREVALENCE; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84982792287     PISSN: 17843227     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Grebely J., Robaeys G., Bruggmann P., Aghemo A., Backmund M., Bruneau J., Byrne J. et al. Recommendations for the management of hepatitis C virus infection among people who inject drugs. Int. J. Drug Policy, 2015, 26: 1028-1038.
2. Bollaerts K., Aerts M., Sasse A. Improved benchmark-multiplier method to estimate the prevalence of ever-injecting drug use in Belgium, 2000-10. Arch. Public Health, 2013, 71: 10.
3. Plettinckx E., Antoine J., Blanckaert P., De Ridder K., Vander Laenen F., Laudens F., Casero L. et al. Belgian National Report on drugs 2014, New Developments and Trends. Brussels, Belgium, 2014.
4. European Monitoring Centre for D, Drug A. Country overview: Belgium. Key statistics on the drug situation in Belgium, 2014.
5. Doerrbecker J., Behrendt P., Mateu-Gelabert P., Ciesek S., Riebesehl N., Wilhelm C., Steinmann J. et al. Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment. J. Infect. Dis., 2013, 207: 281-287.
6. Razavi H., Elkhoury A.C., Elbasha E., Estes C., Pasini K., Poynard T., Kumar R. Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology, 2013, 57: 2164-2170.
7. Razavi H., Waked I., Sarrazin C., Myers R.P., Idilman R., Calinas F., Vogel W. et al. The present and future disease burden of hepatitis C virus (HCV) infection with today’s treatment paradigm. J. Viral. Hepat., 2014, 21 Suppl 1: 34-59.
8. Vandijck D., Moreno C., Starkel P., Van Damme P., van Vlierberghe H., Hindman S.J., Razavi H. et al. Current and future health and economic impact of hepatitis C in Belgium. Acta Gastroenterol. Belg., 2014, 77: 285-290.
9. Centers for Disease C., Prevention. Recommendations for follow-up of health care workers after occupational exposure to hepatitis C virus. MMWR, 1997, 46: 603-606.
10. Mitsui T., Iwano K., Masuko K., Yamazaki C., Okamoto H., Tsuda F., Tanaka T. et al. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology, 1992, 16: 1109-1114.
11. Hasan F., Askar H., Al Khalidi J., Al Shamali M., Al Kalaoui M., Al Nakib B. Lack of transmission of hepatitis C virus following needlestick accidents. Hepatogastroenterology, 1999, 46: 1678-1681.
12. Tsui J.I., Evans J.L., Lum P.J., Hahn J.A., Page K. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users. JAMA Intern. Med., 2014, 174: 1974-1981.
13. Turner K.M., Hutchinson S., Vickerman P., Hope V., Craine N., Palmateer N., May M. et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction, 2011, 2011/05/28: 1978-1988.
14. Van Den Berg C., Smit C., Van Brussel G., Coutinho R., Prins M., Amsterdam C. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction, 2007, 102: 1454-1462.
15. White B., Dore G.J., Lloyd A.R., Rawlinson W.D., Maher L. Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study. Med. J. Aust., 2014, 201: 326-329.
16. Hagan H., Pouget E.R., Des Jarlais D.C. A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J. Infect. Dis., 2011, 204: 74-83.
17. MacArthur G.J., van Velzen E., Palmateer N., Kimber J., Pharris A., Hope V., Taylor A. et al. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int. J. Drug Policy, 2014, 25: 34-52.
18. Bmcdda. Belgian national report on drugs, 2013. Brussels, Belgium: Belgian Monitoring Center for Drugs and Drug Addiction, 2013. Report No.: D/2013/2505.
19. Gower E., Estes C., Blach S., Razavi-Shearer K., Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. Journal of Hepatology, 2014, 61: S45-S57.
20. Van Damme P., Laleman W., Starkel P., van Vlierberghe H., Vandijck D., Hindman S.J., Razavi H. et al. Hepatitis C Epidemiology in Belgium. Acta Gastroenterol. Belg., 2014, 77: 277-279.
21. Emcdda. High risk drug use-Injecting-% injecting in treatment: European Monitoring Centre for Drugs and Drug Addiction, 2014.
22. Mathei C., Shkedy Z., Denis B., Kabali C., Aerts M., Molenberghs G., Van Damme P. et al. Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users. J. Viral. Hepat., 2006, 13: 560-570.
23. Belgium S. Prison Population. In. Statistics Belgium, 2014.
24. International Centre for Prison S. Belgium-Pre-trial/remand prison population: trend, 2015.